Skip to main content

Table 3 Results of univariate log-rank analysis of prognostic factors for bone recurrence-free survival in all patients (n = 161) receiving esophagectomy or stage II + III patients (n = 133) receiving esophagectomy

From: Is there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma

Factors

No. of patients (All, n= 161)

Bone recurrence-free survival (All, n = 161)

No. of patients (Stage II + III, n = 133)

Bone recurrence-free survival (Stage II + III, n = 133)

No. of events

P value

No. of events

P value

Bone scan before op

      

Absent

42

6

0.009*

34

6

0.003*

Present

119

4

 

99

4

 

Sex

      

Male

156

10

0.480

129

10

0.475

Female

5

0

 

4

0

 

Age

      

<55y/o

88

4

0.417

71

4

0.584

>55y/o

73

6

 

62

6

 

Tumor location

      

Upper/middle

82

4

0.514

66

4

0.555

Lower

79

6

 

67

6

 

Protocol

      

Op

95

5

0.336

69

5

0.715

Pre-op CCRT + op

66

5

 

64

5

 

T stage

      

T1 + 2

53

2

0.160

25

2

0.757

T3 + 4

108

8

 

108

8

 

N stage

      

Negative

75

2

0.014*

47

2

0.100

Positive

86

8

 

86

8

 

7thAJCC stage

      

I + II

80

2

0.004*

52

2

0.037*

III

81

8

 

81

8

 

Surgical margin

      

Positive

12

0

0.505

10

0

0.604

Negative

149

10

 

123

10

 
  1. Op, operation; CCRT, concurrent chemoradiotherapy *Statistically significant.